Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
480
datasets available to search
ShareScore release 0.7.1
Dataset results
480 results for “Hormone Receptors”
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT05464810. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
ClinicalTrials.gov study NCT07205822. IPD Sharing: YES. Countries: 6. Publications: 0.
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
ClinicalTrials.gov study NCT06018337. IPD Sharing: NO. Countries: 17. Publications: 0.
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT04086875. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
ClinicalTrials.gov study NCT06361940. IPD Sharing: NO. Countries: 1. Publications: 0.
Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer
ClinicalTrials.gov study NCT04460430. IPD Sharing: NO. Countries: 2. Publications: 0.
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
ClinicalTrials.gov study NCT07140900. IPD Sharing: YES. Countries: 3. Publications: 0.
Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With F
ClinicalTrials.gov study NCT03873428. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00811369. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative
ClinicalTrials.gov study NCT07330544. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2-negative Early High-risk Breast Cancer
ClinicalTrials.gov study NCT06791161. IPD Sharing: NO. Countries: 1. Publications: 0.
Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT02511639. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT07294339. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe)
ClinicalTrials.gov study NCT02269813. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative
ClinicalTrials.gov study NCT04842617. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
ClinicalTrials.gov study NCT00552851. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan
ClinicalTrials.gov study NCT02924584. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensiti
ClinicalTrials.gov study NCT06473259. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
ClinicalTrials.gov study NCT05362760. IPD Sharing: NO. Countries: 2. Publications: 0.
BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT01791478. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.